Foxa1 and foxa2 are required for the maintenance of dopaminergic properties in ventral midbrain neurons at late embryonic stages
The maintained expression of transcription factors throughout the development of mesodiencephalic dopaminergic (mDA) neurons suggests multiple roles at various stages in development. Two members of the forkhead/winged helix transcription factor family, Foxa1 and Foxa2, have been recently shown to ha...
Gespeichert in:
Veröffentlicht in: | The Journal of neuroscience 2013-05, Vol.33 (18), p.8022-8034 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 8034 |
---|---|
container_issue | 18 |
container_start_page | 8022 |
container_title | The Journal of neuroscience |
container_volume | 33 |
creator | Stott, Simon R W Metzakopian, Emmanouil Lin, Wei Kaestner, Klaus H Hen, Rene Ang, Siew-Lan |
description | The maintained expression of transcription factors throughout the development of mesodiencephalic dopaminergic (mDA) neurons suggests multiple roles at various stages in development. Two members of the forkhead/winged helix transcription factor family, Foxa1 and Foxa2, have been recently shown to have an important influence in the early development of mDA neurons. Here we present data demonstrating that these genes are also involved in the later maintenance of the mDA system. We conditionally removed both genes in postmitotic mDA neurons using the dopamine transporter-cre mouse. Deletion of both Foxa1 and Foxa2 resulted in a significant reduction in the number of tyrosine hydroxylase (TH)-positive mDA neurons. The decrease was predominantly observed in the substantia nigra region of the mDA system, which led to a loss of TH+ fibers innervating the striatum. Further analysis demonstrated that the reduction in the number of TH+ cells in the mutant mice was not due to apoptosis or cell-fate change. Using reporter mouse lines, we found that the mDA neurons were still present in the ventral midbrain, but that they had lost much of their dopaminergic phenotype. The majority of these neurons remained in the ventral mesencephalon until at least 18 months of age. Chromatin immunoprecipitation suggested that the loss of the mDA phenotype is due to a reduction in the binding of the nuclear orphan receptor, Nurr-1 to the promoter region of TH. These results extend previous findings and demonstrate a later role for Foxa genes in regulating the maintenance of dopaminergic phenotype in mDA neurons. |
doi_str_mv | 10.1523/jneurosci.4774-12.2013 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6618950</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1348498978</sourcerecordid><originalsourceid>FETCH-LOGICAL-c513t-52cc2e6b43136ecc188e9d4fa582631a5450ce4367e9c6e8fcd61d1d26e49c1f3</originalsourceid><addsrcrecordid>eNqFkU9v1DAQxS0EokvhK1Q-csnW439JLkho1dKiikpAz5bXmWxdJXZqOxW98dHJsqWCE6exZt57etaPkBNga1BcnN4FnFPMzq9lXcsK-JozEC_Iarm2FZcMXpIV4zWrtKzlEXmT8x1jrGZQvyZHXGhRQ8tX5Od5_GGB2tDRfnlxahPShPezT7hfJVpukY7Wh4LBBoc09rSLkx19wLTzjk4pTpiKx0x9oA8YSrIDHX23TYuL_u4ZMrWFDrYgxXGbHmNYjLnYHea35FVvh4zvnuYxuTk_-765qK6uP11uPl5VToEoleLOcdRbKUBodA6aBttO9lY1XAuwSirmUApdY-s0Nr3rNHTQcY2yddCLY_LhkDvN2xE7d-hppuRHmx5NtN78ewn-1uzig9EamlaxJeD9U0CK9zPmYkafHQ6DDRjnbEAp0LzRXP1fKmQj26atm0WqD1K30MwJ--dGwMyetPn85ezm6_W3zaXZkzbAzZ70Yjz5-z_Ptj9oxS_ilKnf</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1348498978</pqid></control><display><type>article</type><title>Foxa1 and foxa2 are required for the maintenance of dopaminergic properties in ventral midbrain neurons at late embryonic stages</title><source>MEDLINE</source><source>PubMed Central(OpenAccess)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Stott, Simon R W ; Metzakopian, Emmanouil ; Lin, Wei ; Kaestner, Klaus H ; Hen, Rene ; Ang, Siew-Lan</creator><creatorcontrib>Stott, Simon R W ; Metzakopian, Emmanouil ; Lin, Wei ; Kaestner, Klaus H ; Hen, Rene ; Ang, Siew-Lan</creatorcontrib><description>The maintained expression of transcription factors throughout the development of mesodiencephalic dopaminergic (mDA) neurons suggests multiple roles at various stages in development. Two members of the forkhead/winged helix transcription factor family, Foxa1 and Foxa2, have been recently shown to have an important influence in the early development of mDA neurons. Here we present data demonstrating that these genes are also involved in the later maintenance of the mDA system. We conditionally removed both genes in postmitotic mDA neurons using the dopamine transporter-cre mouse. Deletion of both Foxa1 and Foxa2 resulted in a significant reduction in the number of tyrosine hydroxylase (TH)-positive mDA neurons. The decrease was predominantly observed in the substantia nigra region of the mDA system, which led to a loss of TH+ fibers innervating the striatum. Further analysis demonstrated that the reduction in the number of TH+ cells in the mutant mice was not due to apoptosis or cell-fate change. Using reporter mouse lines, we found that the mDA neurons were still present in the ventral midbrain, but that they had lost much of their dopaminergic phenotype. The majority of these neurons remained in the ventral mesencephalon until at least 18 months of age. Chromatin immunoprecipitation suggested that the loss of the mDA phenotype is due to a reduction in the binding of the nuclear orphan receptor, Nurr-1 to the promoter region of TH. These results extend previous findings and demonstrate a later role for Foxa genes in regulating the maintenance of dopaminergic phenotype in mDA neurons.</description><identifier>ISSN: 0270-6474</identifier><identifier>ISSN: 1529-2401</identifier><identifier>EISSN: 1529-2401</identifier><identifier>DOI: 10.1523/jneurosci.4774-12.2013</identifier><identifier>PMID: 23637192</identifier><language>eng</language><publisher>United States: Society for Neuroscience</publisher><subject>Analysis of Variance ; Animals ; Bacterial Proteins - metabolism ; Cell Death - genetics ; Cell Differentiation - genetics ; Cell Movement - genetics ; Cell Size ; Chromatin Immunoprecipitation ; Dopamine Plasma Membrane Transport Proteins - genetics ; Dopaminergic Neurons - physiology ; Embryo, Mammalian ; Gait - genetics ; Gene Expression Regulation, Developmental - genetics ; Hepatocyte Nuclear Factor 3-alpha - deficiency ; Hepatocyte Nuclear Factor 3-alpha - metabolism ; Hepatocyte Nuclear Factor 3-beta - deficiency ; Hepatocyte Nuclear Factor 3-beta - metabolism ; In Situ Nick-End Labeling ; Luminescent Proteins - metabolism ; Mesencephalon - cytology ; Mesencephalon - embryology ; Mice ; Mice, Transgenic ; Mutation - genetics ; Nerve Fibers - physiology ; Nerve Tissue Proteins - metabolism ; Protein Binding - genetics ; Proteins - genetics ; Proteins - metabolism ; RNA, Untranslated ; Tyrosine 3-Monooxygenase - metabolism</subject><ispartof>The Journal of neuroscience, 2013-05, Vol.33 (18), p.8022-8034</ispartof><rights>Copyright © 2013 the authors 0270-6474/13/338022-13$15.00/0 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c513t-52cc2e6b43136ecc188e9d4fa582631a5450ce4367e9c6e8fcd61d1d26e49c1f3</citedby><cites>FETCH-LOGICAL-c513t-52cc2e6b43136ecc188e9d4fa582631a5450ce4367e9c6e8fcd61d1d26e49c1f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618950/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618950/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23637192$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stott, Simon R W</creatorcontrib><creatorcontrib>Metzakopian, Emmanouil</creatorcontrib><creatorcontrib>Lin, Wei</creatorcontrib><creatorcontrib>Kaestner, Klaus H</creatorcontrib><creatorcontrib>Hen, Rene</creatorcontrib><creatorcontrib>Ang, Siew-Lan</creatorcontrib><title>Foxa1 and foxa2 are required for the maintenance of dopaminergic properties in ventral midbrain neurons at late embryonic stages</title><title>The Journal of neuroscience</title><addtitle>J Neurosci</addtitle><description>The maintained expression of transcription factors throughout the development of mesodiencephalic dopaminergic (mDA) neurons suggests multiple roles at various stages in development. Two members of the forkhead/winged helix transcription factor family, Foxa1 and Foxa2, have been recently shown to have an important influence in the early development of mDA neurons. Here we present data demonstrating that these genes are also involved in the later maintenance of the mDA system. We conditionally removed both genes in postmitotic mDA neurons using the dopamine transporter-cre mouse. Deletion of both Foxa1 and Foxa2 resulted in a significant reduction in the number of tyrosine hydroxylase (TH)-positive mDA neurons. The decrease was predominantly observed in the substantia nigra region of the mDA system, which led to a loss of TH+ fibers innervating the striatum. Further analysis demonstrated that the reduction in the number of TH+ cells in the mutant mice was not due to apoptosis or cell-fate change. Using reporter mouse lines, we found that the mDA neurons were still present in the ventral midbrain, but that they had lost much of their dopaminergic phenotype. The majority of these neurons remained in the ventral mesencephalon until at least 18 months of age. Chromatin immunoprecipitation suggested that the loss of the mDA phenotype is due to a reduction in the binding of the nuclear orphan receptor, Nurr-1 to the promoter region of TH. These results extend previous findings and demonstrate a later role for Foxa genes in regulating the maintenance of dopaminergic phenotype in mDA neurons.</description><subject>Analysis of Variance</subject><subject>Animals</subject><subject>Bacterial Proteins - metabolism</subject><subject>Cell Death - genetics</subject><subject>Cell Differentiation - genetics</subject><subject>Cell Movement - genetics</subject><subject>Cell Size</subject><subject>Chromatin Immunoprecipitation</subject><subject>Dopamine Plasma Membrane Transport Proteins - genetics</subject><subject>Dopaminergic Neurons - physiology</subject><subject>Embryo, Mammalian</subject><subject>Gait - genetics</subject><subject>Gene Expression Regulation, Developmental - genetics</subject><subject>Hepatocyte Nuclear Factor 3-alpha - deficiency</subject><subject>Hepatocyte Nuclear Factor 3-alpha - metabolism</subject><subject>Hepatocyte Nuclear Factor 3-beta - deficiency</subject><subject>Hepatocyte Nuclear Factor 3-beta - metabolism</subject><subject>In Situ Nick-End Labeling</subject><subject>Luminescent Proteins - metabolism</subject><subject>Mesencephalon - cytology</subject><subject>Mesencephalon - embryology</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Mutation - genetics</subject><subject>Nerve Fibers - physiology</subject><subject>Nerve Tissue Proteins - metabolism</subject><subject>Protein Binding - genetics</subject><subject>Proteins - genetics</subject><subject>Proteins - metabolism</subject><subject>RNA, Untranslated</subject><subject>Tyrosine 3-Monooxygenase - metabolism</subject><issn>0270-6474</issn><issn>1529-2401</issn><issn>1529-2401</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU9v1DAQxS0EokvhK1Q-csnW439JLkho1dKiikpAz5bXmWxdJXZqOxW98dHJsqWCE6exZt57etaPkBNga1BcnN4FnFPMzq9lXcsK-JozEC_Iarm2FZcMXpIV4zWrtKzlEXmT8x1jrGZQvyZHXGhRQ8tX5Od5_GGB2tDRfnlxahPShPezT7hfJVpukY7Wh4LBBoc09rSLkx19wLTzjk4pTpiKx0x9oA8YSrIDHX23TYuL_u4ZMrWFDrYgxXGbHmNYjLnYHea35FVvh4zvnuYxuTk_-765qK6uP11uPl5VToEoleLOcdRbKUBodA6aBttO9lY1XAuwSirmUApdY-s0Nr3rNHTQcY2yddCLY_LhkDvN2xE7d-hppuRHmx5NtN78ewn-1uzig9EamlaxJeD9U0CK9zPmYkafHQ6DDRjnbEAp0LzRXP1fKmQj26atm0WqD1K30MwJ--dGwMyetPn85ezm6_W3zaXZkzbAzZ70Yjz5-z_Ptj9oxS_ilKnf</recordid><startdate>20130501</startdate><enddate>20130501</enddate><creator>Stott, Simon R W</creator><creator>Metzakopian, Emmanouil</creator><creator>Lin, Wei</creator><creator>Kaestner, Klaus H</creator><creator>Hen, Rene</creator><creator>Ang, Siew-Lan</creator><general>Society for Neuroscience</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope><scope>5PM</scope></search><sort><creationdate>20130501</creationdate><title>Foxa1 and foxa2 are required for the maintenance of dopaminergic properties in ventral midbrain neurons at late embryonic stages</title><author>Stott, Simon R W ; Metzakopian, Emmanouil ; Lin, Wei ; Kaestner, Klaus H ; Hen, Rene ; Ang, Siew-Lan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c513t-52cc2e6b43136ecc188e9d4fa582631a5450ce4367e9c6e8fcd61d1d26e49c1f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Analysis of Variance</topic><topic>Animals</topic><topic>Bacterial Proteins - metabolism</topic><topic>Cell Death - genetics</topic><topic>Cell Differentiation - genetics</topic><topic>Cell Movement - genetics</topic><topic>Cell Size</topic><topic>Chromatin Immunoprecipitation</topic><topic>Dopamine Plasma Membrane Transport Proteins - genetics</topic><topic>Dopaminergic Neurons - physiology</topic><topic>Embryo, Mammalian</topic><topic>Gait - genetics</topic><topic>Gene Expression Regulation, Developmental - genetics</topic><topic>Hepatocyte Nuclear Factor 3-alpha - deficiency</topic><topic>Hepatocyte Nuclear Factor 3-alpha - metabolism</topic><topic>Hepatocyte Nuclear Factor 3-beta - deficiency</topic><topic>Hepatocyte Nuclear Factor 3-beta - metabolism</topic><topic>In Situ Nick-End Labeling</topic><topic>Luminescent Proteins - metabolism</topic><topic>Mesencephalon - cytology</topic><topic>Mesencephalon - embryology</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Mutation - genetics</topic><topic>Nerve Fibers - physiology</topic><topic>Nerve Tissue Proteins - metabolism</topic><topic>Protein Binding - genetics</topic><topic>Proteins - genetics</topic><topic>Proteins - metabolism</topic><topic>RNA, Untranslated</topic><topic>Tyrosine 3-Monooxygenase - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stott, Simon R W</creatorcontrib><creatorcontrib>Metzakopian, Emmanouil</creatorcontrib><creatorcontrib>Lin, Wei</creatorcontrib><creatorcontrib>Kaestner, Klaus H</creatorcontrib><creatorcontrib>Hen, Rene</creatorcontrib><creatorcontrib>Ang, Siew-Lan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stott, Simon R W</au><au>Metzakopian, Emmanouil</au><au>Lin, Wei</au><au>Kaestner, Klaus H</au><au>Hen, Rene</au><au>Ang, Siew-Lan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Foxa1 and foxa2 are required for the maintenance of dopaminergic properties in ventral midbrain neurons at late embryonic stages</atitle><jtitle>The Journal of neuroscience</jtitle><addtitle>J Neurosci</addtitle><date>2013-05-01</date><risdate>2013</risdate><volume>33</volume><issue>18</issue><spage>8022</spage><epage>8034</epage><pages>8022-8034</pages><issn>0270-6474</issn><issn>1529-2401</issn><eissn>1529-2401</eissn><abstract>The maintained expression of transcription factors throughout the development of mesodiencephalic dopaminergic (mDA) neurons suggests multiple roles at various stages in development. Two members of the forkhead/winged helix transcription factor family, Foxa1 and Foxa2, have been recently shown to have an important influence in the early development of mDA neurons. Here we present data demonstrating that these genes are also involved in the later maintenance of the mDA system. We conditionally removed both genes in postmitotic mDA neurons using the dopamine transporter-cre mouse. Deletion of both Foxa1 and Foxa2 resulted in a significant reduction in the number of tyrosine hydroxylase (TH)-positive mDA neurons. The decrease was predominantly observed in the substantia nigra region of the mDA system, which led to a loss of TH+ fibers innervating the striatum. Further analysis demonstrated that the reduction in the number of TH+ cells in the mutant mice was not due to apoptosis or cell-fate change. Using reporter mouse lines, we found that the mDA neurons were still present in the ventral midbrain, but that they had lost much of their dopaminergic phenotype. The majority of these neurons remained in the ventral mesencephalon until at least 18 months of age. Chromatin immunoprecipitation suggested that the loss of the mDA phenotype is due to a reduction in the binding of the nuclear orphan receptor, Nurr-1 to the promoter region of TH. These results extend previous findings and demonstrate a later role for Foxa genes in regulating the maintenance of dopaminergic phenotype in mDA neurons.</abstract><cop>United States</cop><pub>Society for Neuroscience</pub><pmid>23637192</pmid><doi>10.1523/jneurosci.4774-12.2013</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0270-6474 |
ispartof | The Journal of neuroscience, 2013-05, Vol.33 (18), p.8022-8034 |
issn | 0270-6474 1529-2401 1529-2401 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6618950 |
source | MEDLINE; PubMed Central(OpenAccess); EZB-FREE-00999 freely available EZB journals |
subjects | Analysis of Variance Animals Bacterial Proteins - metabolism Cell Death - genetics Cell Differentiation - genetics Cell Movement - genetics Cell Size Chromatin Immunoprecipitation Dopamine Plasma Membrane Transport Proteins - genetics Dopaminergic Neurons - physiology Embryo, Mammalian Gait - genetics Gene Expression Regulation, Developmental - genetics Hepatocyte Nuclear Factor 3-alpha - deficiency Hepatocyte Nuclear Factor 3-alpha - metabolism Hepatocyte Nuclear Factor 3-beta - deficiency Hepatocyte Nuclear Factor 3-beta - metabolism In Situ Nick-End Labeling Luminescent Proteins - metabolism Mesencephalon - cytology Mesencephalon - embryology Mice Mice, Transgenic Mutation - genetics Nerve Fibers - physiology Nerve Tissue Proteins - metabolism Protein Binding - genetics Proteins - genetics Proteins - metabolism RNA, Untranslated Tyrosine 3-Monooxygenase - metabolism |
title | Foxa1 and foxa2 are required for the maintenance of dopaminergic properties in ventral midbrain neurons at late embryonic stages |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T09%3A08%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Foxa1%20and%20foxa2%20are%20required%20for%20the%20maintenance%20of%20dopaminergic%20properties%20in%20ventral%20midbrain%20neurons%20at%20late%20embryonic%20stages&rft.jtitle=The%20Journal%20of%20neuroscience&rft.au=Stott,%20Simon%20R%20W&rft.date=2013-05-01&rft.volume=33&rft.issue=18&rft.spage=8022&rft.epage=8034&rft.pages=8022-8034&rft.issn=0270-6474&rft.eissn=1529-2401&rft_id=info:doi/10.1523/jneurosci.4774-12.2013&rft_dat=%3Cproquest_pubme%3E1348498978%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1348498978&rft_id=info:pmid/23637192&rfr_iscdi=true |